Effects of Streptokinase and Urokinase on Microarterial Thrombosis and Haemostasis:An experimental study in rabbits
- 1 January 1994
- journal article
- Published by Taylor & Francis in Scandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery
- Vol. 28 (1) , 9-13
- https://doi.org/10.3109/02844319409015988
Abstract
The effects of streptokinase and urokinase on haemostasis, accumulation of platelets radiolabelled with phosphorus (32P) and patency were studied after arteriotomy and deep vessel wall trauma of the central arteries of rabbits' ears. In one study, 12 rabbits were given 1700 IU/kg body weight of streptokinase or urokinase as intraaortic bolus injections five minutes before vascular reperfusion (opening of vascular clamps). A further six were given saline (controls). In the second, 12 further rabbits were each given 3,400 IU/kg of either substance, one fifth as a bolus before reperfusion and the remainder as a continuous infusion during the next two hours. A further six were given saline (controls). Irrespective of the dosage regimens, neither substance improved patency compared with saline-treated controls. Separate dose response studies with streptokinase showed that bolus or bolus+infusion doses larger than those given caused troublesome arteriotomy bleeding. Compared with controls, streptokinase increased, and urokinase decreased, accumulation of platelets. This was not reflected in differences in patency rates, which were similar in all groups. In conclusion, fibrinolytic stimulation with non-thrombolytic doses of streptokinase or urokinase did not prevent microarterial thrombosis in rabbits. The therapeutic index for these substances in clinical microvascular surgery is probably low, as haemorrhagic complications may be expected.Keywords
This publication has 12 references indexed in Scilit:
- Prevention of Microvascular Thrombosis with Low-Dose Tissue Plasminogen ActivatorPlastic and Reconstructive Surgery, 1992
- ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41 299 cases of suspected acute myocardial infarctionPublished by Elsevier ,1992
- International survey of current microvascular practices in free tissue transfer and replantation surgeryMicrosurgery, 1991
- Washout of Vessels with Heparin Does Not Improve Patency Following Severe Microarterial Trauma: An Experimental StudyAnnals of Plastic Surgery, 1990
- Plasminogen activators. The old and the new.Circulation, 1989
- Marked platelet activation in vivo after intravenous streptokinase in patients with acute myocardial infarction.Circulation, 1988
- Tissue-type plasminogen activator and streptokinase induce platelet hyperaggregability in the rabbitThrombosis Research, 1987
- Pharmacokinetic Properties of Anisoylated Plasminogen Streptokinase Activator Complex and Other Thrombolytic Agents in Animals and in HumansDrugs, 1987
- A comparison of the thrombolytic and hemorrhagic effects of tissue-type plasminogen activator and streptokinase in rabbits.Circulation, 1985
- Human extrinsic plasminogen activator fibrinolytic properties and neutralization in vivoThrombosis Research, 1983